MethylGene Inc. (TSX: MYG) today announced that Dr. Jeffrey M. Besterman, Executive Vice President of Research and Development and Chief Scientific Officer of MethylGene will present at the 2006 Medicinal Chemistry Gordon Conference in New London, New Hampshire on Tuesday, August 8th at 8:50 p.m. ET.
